Family Medicine · Yonkers, NY
NPI
1336184290
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
45 Ludlow St, Suite 700
Yonkers, NY, 10705
Phone (914) 375-2700
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
1,247 services
Medicare patients, 2024
87
Average age 76
Drug cost, 2024
$5.4M
27,968 prescriptions
Company payments, 2025
$5,642
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Khalil Innabi was code 99214 (office e&m - established), 284 times for 75 patients. In total Khalil Innabi billed 1,247 services in 39 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 284 | 75 | $102.88 | $29K |
| 36415 Venipuncture Blood Collection | Office | 273 | 82 | $4.90 | $1,338 |
| 82947 Clinical Chemistry | Office | 97 | 32 | $3.85 | $373 |
| 93000 Electrocardiogram | Office | 77 | 62 | $11.15 | $858 |
| 96372 Injection Administration | Office | 59 | 26 | $12.21 | $720 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 58 | 58 | $147.00 | $8,526 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 44 | 17 | $0.93 | $40.73 |
| 99213 Office E&M - Established | Office | 40 | 30 | $67.36 | $2,694 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 27 | 22 | $53.44 | $1,443 |
| 90661 Vaccine Product | Office | 26 | 26 | $36.11 | $939 |
| G0008 Administration of influenza virus vaccine | Office | 25 | 25 | $37.09 | $927 |
| 90471 Vaccine Administration | Office | 23 | 21 | $18.45 | $424 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 22 | 22 | $72.69 | $1,599 |
| 81002 Clinical Chemistry | Office | 21 | 16 | $3.41 | $71.61 |
| 99442 Telephone Services | Office | 13 | 12 | $66.63 | $866 |
By year: 2022 $70K for 1,673 services; 2023 $60K for 1,358 services; 2024 $57K for 1,247 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 273 | 82 | $4.90 | $1,338 |
| 82947 Clinical Chemistry | 97 | 32 | $3.85 | $373 |
| 81002 Clinical Chemistry | 21 | 16 | $3.41 | $71.61 |
Medicare prescription drug claims, 2024
In 2024, the drug Khalil Innabi prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,002 prescriptions and refills. In total Khalil Innabi wrote 27,968 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,002 | 1,959 | 194 | $8,116 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 934 | 1,534 | 168 | $2,166 |
| Atorvastatin Calcium Generic | 901 | 1,593 | 161 | $5,547 |
| Amlodipine Besylate Generic | 743 | 1,441 | 143 | $2,939 |
| Losartan Potassium Generic | 708 | 1,192 | 118 | $3,925 |
| Metoprolol Succinate Generic | 664 | 1,299 | 123 | $8,692 |
| Pantoprazole Sodium Generic | 637 | 1,167 | 138 | $4,507 |
| Gabapentin Generic | 624 | 1,067 | 98 | $3,743 |
| Diclofenac Sodium Generic | 602 | 1,039 | 188 | $46K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 541 | 1,062 | 148 | $36K |
| Linzess Linaclotide | 527 | 736 | 97 | $371K |
| Levothyroxine Sodium Generic | 469 | 954 | 83 | $5,554 |
| Vascepa Icosapent Ethyl | 456 | 598 | 67 | $197K |
| Tamsulosin Hcl Generic | 435 | 739 | 83 | $3,897 |
| Omeprazole Generic | 401 | 814 | 88 | $3,886 |
Brand drugs: 7,610 claims; generic drugs: 19,557 claims; opioid claims: 432.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Khalil Innabi $5,642 ($5,642 in general payments such as food, travel and fees) from 32 companies. The largest payer was Abbvie Inc. with $1,085.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 44 | $1,085 |
| Novo Nordisk Inc NVO | 20 | $400 |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $367 |
| Amgen Inc. AMGN | 20 | $357 |
| Astellas Pharma US Inc 4503.T | 9 | $314 |
| Scilex Pharmaceuticals Inc. | 14 | $282 |
| Ardelyx, Inc. ARDX | 14 | $279 |
| Esperion Therapeutics, Inc. ESPR | 11 | $251 |
| Lundbeck LLC | 9 | $212 |
| GlaxoSmithKline, LLC. GSK | 8 | $203 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.